Skip to main content

RT @RichardPAConway: Johnson et al TYK2i deucravacitinib does not inhibit haematologic pathways, Treg function, or IL-15

Nov 13, 2022 9:52 am
Social Author Name
Richard Conway
Tweet Content
Johnson et al TYK2i deucravacitinib does not inhibit haematologic pathways, Treg function, or IL-15 dependent NK cell function, that JAKi do. @rheumnow #ACR22 Abstr#0584 https://t.co/UTHzUjGmJN https://t.co/NUKKAv3tAr
Show on Archive Page
On
Display in Search Results
On
PDQ
Off
×